CVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access

On Behalf of Investors of CVRx, Inc. - CVRX NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is

SAN FRANCISCO, Aug. 26, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights litigation

NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

MINNEAPOLIS, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stag

Boston, Massachusetts--(Newsfile Corp. - August 24, 2026) - Block & Leviton is investigating CVRx, I

Delivers Letter to the CVRx Board Highlighting Significant Value Proposition of Barostim to a Large

MINNEAPOLIS, Aug. 24, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stag

Delivers Letter to the CVRx Board Highlighting Significant Value Proposition of Barostim to a Large

SAN FRANCISCO, Aug. 19, 2026 /PRNewswire/ -- Hagens Berman, a national shareholder rights litigation

Boston, Massachusetts--(Newsfile Corp. - August 18, 2026) - Block & Leviton is investigating CVRx, I

Cantor Fitzgerald analyst Sarah James maintains CVRx (NASDAQ:CVRX) with a Overweight and lowers t

SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Hagens Berman, a national shareholder rights litiga

Boston, Massachusetts--(Newsfile Corp. - August 13, 2026) - Block & Leviton is investigating CVRx, I

CVRx NASDAQ: CVRX outlined its efforts to expand adoption of its Barostim therapy for heart failure

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of CVRx, I

Law Offices of Howard G. Smith announces an investigation on behalf of CVRx, Inc. (“CVRx” or the

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder righ

BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating CVRx, Inc. (Nasdaq: CVRX)

San Diego, California--(Newsfile Corp. - August 7, 2026) - Johnson Fistel, PLLP is investigating whe

Lake Street analyst Frank Takkinen downgrades CVRx (NASDAQ:CVRX) from Buy to Hold and lowers the

Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session.

SAN DIEGO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether CVRx, Inc

Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The

Atlassian Corp (NASDAQ: TEAM) reported strong Q4 results, beating revenue and earnings estimates. St

CVRx stock sinks after hours after lowering full-year revenue outlook despite revenue growth.

Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market

CVRx (NASDAQ:CVRX) lowers FY2026 sales outlook from $63.000 million-$67.000 million to $58.000 milli

CVRx, Inc. (NASDAQ:CVRX) ("CVRx"), a commercial-stage medical device company focused on deve

Humana, a national health insurance company with the second largest Medicare Advantage program in th

CVRx (NASDAQ:CVRX) affirms FY2026 sales outlook from $63.000 million-$67.000 million to $63.000 mill

CVRx (NASDAQ:CVRX) reported quarterly losses of $(0.50) per share which beat the analyst consensus e

CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commerc